Tom Kim
Chief Financial Officer
Replay available
European Wax Center, Inc. (NASDAQ: EWCZ) Q2 2025 earnings conference call, held 2025-08-13. Replay captured from the company's public earnings webcast.

Chief Financial Officer
Chairman and Chief Executive Officer
Analyst, Jefferies
Analyst, Truist
CEO & Chief Research Officer, Telsey Advisory Group
Analyst, Bayard Research
Analyst, Guggenheim
Good morning, ladies and gentlemen. Thank you for standing by. Welcome to European WAC Center second quarter 2025 earnings results call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. In order to facilitate as many participants as possible, we ask that you please limit yourself to one question and one follow-up during the Q&A session. If you have additional questions, you may rejoin the queue. On the call today is Chris Morris, Chairman and Chief Executive Officer, and Tom Kim, Chief Financial Officer. I would like now to turn the conference over to Tom Kim, Chief Financial Officer. Sir, you may begin. Good morning, everyone. Thank you and welcome to European WAF Center's second quarter fiscal year 2025 earnings call. On today's call, Chris Morris will provide an update on the company's performance and discuss additional details regarding progress made on our priorities. Then I will discuss our second quarter results and fiscal 2025 outlook. Following the prepared remarks, we'll be available to take questions. Before we start, I would like to remind you of our legal disclaimer. We will make certain statements today which are forward-looking within the meaning of the federal securities laws. including statements about the outlook of our business and other matters referenced in our earnings released issued today. These forward-looking statements involve a number of risks and uncertainties that could cause actual results to differ materially. Please refer to our SEC filings as well as our earnings released issued today for a more detailed description of the risk factors that may affect our results. Please also note that these forward-looking statements reflect our opinions only as ...